Loading...

Radu O. Minea, MD

TitleAssistant Professor of Research Neurological Surgery
InstitutionUniversity of Southern California
DepartmentNeurological Surgery
AddressHMR 2011 Zonal Avenue 414
Health Sciences Campus
Los Angeles CA 90089-0110
Phone+1 323 442 5680
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Janib SM, Gustafson JA, Minea R, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti PS, Li Z, MacKay JA. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. PMID: 24871936; PMCID: PMC4098058.
    2. Minea R, Helchowski C, Rubino B, Brodmann K, Swenson S, Markland F. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. Toxicon. 2012 Mar 15; 59(4):472-86. PMID: 21354198; PMCID: PMC3130806.
    3. Minea R, Helchowski CM, Zidovetzki SJ, Costa FK, Swenson SD, Markland FS. Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One. 2010 Jun 03; 5(6):e10929. PMID: 20532165; PMCID: PMC2880590.
    4. Helchowski CM, Minea R, Swenson SD, Markland FS. The use of pepsin in receptor internalization assays. Biochem Biophys Res Commun. 2009 Oct 16; 388(2):240-6. PMID: 19665997.
      View in: PubMed
    5. Minea R, Swenson S, Costa F, Chen TC, Markland FS. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb. 2005; 34(4-5):177-83. PMID: 16707923.
      View in: PubMed
    6. Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, Yang D, Markland FS. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004 Apr; 3(4):499-511. PMID: 15078994.
      View in: PubMed
    Radu's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _